Profile for Myovant Sciences Ltd. (MYOV)

$ 7.80   0.10 (+1.30%) Volume: 310.66k 1:53 PM EDT 3-Apr-2020
Business Description:
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.
Address: 11-12 St. James's Square, Suite 1, 3rd Floor, London, GBR, SW1Y 4LB
Telephone: +44 12955950 Website:
Facsimile: N/A Email: [email protected]
CEO: Lynn Seely
Employees: 167 Market Cap: 700.35m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1679082
Industry: Biotechnology
Sub-Industry:    Biotechnology